Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Jake Liang

Showing results (161-170 of 187) with videos related to

Pageof 19
Sort By:
Journal of Medicinal Chemistry|June 29, 2021
Discovery and Optimization of a 4-Aminopiperidine Scaffold for Inhibition of Hepatitis C Virus AssemblyAdam Rolt, Daniel C Talley, Seung Bum Park, et al.
Antiviral Research|February 4, 2019
A randomized, proof-of-concept clinical trial on repurposing chlorcyclizine for the treatment of chronic hepatitis CChristopher Koh, Preeti Dubey, Ma Ai Thanda Han, et al.
Journal of Medicinal Chemistry|June 22, 2017
Development of an Aryloxazole Class of Hepatitis C Virus Inhibitors Targeting the Entry Stage of the Viral Replication CycleShanshan He, Kelin Li, Billy Lin, et al.
Journal of Virology|August 17, 2004
Inhibition of hepatitis C virus-like particle binding to target cells by antiviral antibodies in acute and chronic hepatitis CDaniel Steinmann, Heidi Barth, Bettina Gissler, et al.
Hepatology (Baltimore, Md.)|May 26, 2007
Myxovirus-1 and protein kinase haplotypes and fibrosis in chronic hepatitis C virusLeland J Yee, Yong-Ming Tang, David E Kleiner, et al.
Science Translational Medicine|April 10, 2015
Repurposing of the antihistamine chlorcyclizine and related compounds for treatment of hepatitis C virus infectionShanshan He, Billy Lin, Virginia Chu, et al.
Gastroenterology|January 31, 2003
Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis CKittichai Promrat, David H McDermott, Carlos M Gonzalez, et al.
Hepatology (Baltimore, Md.)|February 28, 2007
Hepatic abnormalities in patients with chronic granulomatous diseaseNadeem Hussain, Jordan J Feld, David E Kleiner, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 7, 2009
Reactivation of hepatitis B with reappearance of hepatitis B surface antigen after chemotherapy and immunosuppressionTara N Palmore, Neeral L Shah, Rohit Loomba, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 12, 2007
A functional SNP of interferon-gamma gene is important for interferon-alpha-induced and spontaneous recovery from hepatitis C virus infectionYing Huang, Huiying Yang, Brian B Borg, et al.
Pageof 19

Showing results (161-170 of 187) with videos related to

Sort By:
Pageof 19
Journal of Medicinal Chemistry|June 29, 2021
Discovery and Optimization of a 4-Aminopiperidine Scaffold for Inhibition of Hepatitis C Virus AssemblyAdam Rolt, Daniel C Talley, Seung Bum Park, et al.
Antiviral Research|February 4, 2019
A randomized, proof-of-concept clinical trial on repurposing chlorcyclizine for the treatment of chronic hepatitis CChristopher Koh, Preeti Dubey, Ma Ai Thanda Han, et al.
Journal of Medicinal Chemistry|June 22, 2017
Development of an Aryloxazole Class of Hepatitis C Virus Inhibitors Targeting the Entry Stage of the Viral Replication CycleShanshan He, Kelin Li, Billy Lin, et al.
Journal of Virology|August 17, 2004
Inhibition of hepatitis C virus-like particle binding to target cells by antiviral antibodies in acute and chronic hepatitis CDaniel Steinmann, Heidi Barth, Bettina Gissler, et al.
Hepatology (Baltimore, Md.)|May 26, 2007
Myxovirus-1 and protein kinase haplotypes and fibrosis in chronic hepatitis C virusLeland J Yee, Yong-Ming Tang, David E Kleiner, et al.
Science Translational Medicine|April 10, 2015
Repurposing of the antihistamine chlorcyclizine and related compounds for treatment of hepatitis C virus infectionShanshan He, Billy Lin, Virginia Chu, et al.
Gastroenterology|January 31, 2003
Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis CKittichai Promrat, David H McDermott, Carlos M Gonzalez, et al.
Hepatology (Baltimore, Md.)|February 28, 2007
Hepatic abnormalities in patients with chronic granulomatous diseaseNadeem Hussain, Jordan J Feld, David E Kleiner, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 7, 2009
Reactivation of hepatitis B with reappearance of hepatitis B surface antigen after chemotherapy and immunosuppressionTara N Palmore, Neeral L Shah, Rohit Loomba, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 12, 2007
A functional SNP of interferon-gamma gene is important for interferon-alpha-induced and spontaneous recovery from hepatitis C virus infectionYing Huang, Huiying Yang, Brian B Borg, et al.
Pageof 19